{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:56:25Z","timestamp":1777089385896,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.mehy.2013.08.016","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T19:00:48Z","timestamp":1377198048000},"page":"923-926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Role of curcumin in idiopathic pulmonary arterial hypertension treatment: A new therapeutic possibility"],"prefix":"10.1016","volume":"81","author":[{"given":"Enrico","family":"Bronte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Di Miceli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Sucato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Novo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.mehy.2013.08.016_b0005","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mehy.2013.08.016_b0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1378\/chest.11-0793","article-title":"Inflammation in pulmonary arterial hypertension","volume":"141","author":"Price","year":"2012","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.mehy.2013.08.016_b0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.mehy.2013.08.016_b0020","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1172\/JCI33452","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"118","author":"Rabinovitch","year":"2008","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.mehy.2013.08.016_b0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cpcardiol.2011.08.002","article-title":"Pulmonary arterial hypertension","volume":"36","author":"McLaughlin","year":"2011","journal-title":"Curr Probl Cardiol"},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2013.08.016_b0030","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"5\u20136","key":"10.1016\/j.mehy.2013.08.016_b0035","first-page":"73","article-title":"Update on therapies for pulmonary hypertension","volume":"137","author":"Ulrich","year":"2007","journal-title":"Swiss Med Wkly"},{"issue":"8","key":"10.1016\/j.mehy.2013.08.016_b0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00392-007-0526-8","article-title":"Pulmonary hypertension: current diagnosis and treatment","volume":"96","author":"Rosenkranz","year":"2007","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"10.1016\/j.mehy.2013.08.016_b0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/138945011794815356","article-title":"The targets of curcumin","volume":"12","author":"Zhou","year":"2011","journal-title":"Curr Drug Targets"},{"issue":"11","key":"10.1016\/j.mehy.2013.08.016_b0050","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1017\/S0007114509993667","article-title":"Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies","volume":"103","author":"Epstein","year":"2010","journal-title":"Br J Nutr"},{"issue":"7","key":"10.1016\/j.mehy.2013.08.016_b0055","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.4049\/jimmunol.171.7.3863","article-title":"Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells","volume":"171","author":"Bharti","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.mehy.2013.08.016_b0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/ars.2007.1769","article-title":"Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials","volume":"10","author":"Strimpakos","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.mehy.2013.08.016_b0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of NF-kappa B in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2013.08.016_b0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mehy.2013.08.016_b0075","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1164\/ajrccm.163.2.2007102","article-title":"Normal responses to injury prevent systemic inflammation and can be immunosuppressive","volume":"163","author":"Munford","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.mehy.2013.08.016_b0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/phrs.1998.0404","article-title":"Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages","volume":"39","author":"Abe","year":"1999","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.mehy.2013.08.016_b0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.2042-7158.1973.tb09131.x","article-title":"Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent","volume":"25","author":"Srimal","year":"1973","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"10.1016\/j.mehy.2013.08.016_b0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0006-2952(97)00557-1","article-title":"Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation","volume":"55","author":"Kumar","year":"1998","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.mehy.2013.08.016_b0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6882-6-10","article-title":"Dose escalation of a curcuminoid formulation","volume":"17","author":"Lao","year":"2006","journal-title":"BMC Complement Altern Med"},{"issue":"4B","key":"10.1016\/j.mehy.2013.08.016_b0100","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions","volume":"21","author":"Cheng","year":"2001"},{"issue":"1","key":"10.1016\/j.mehy.2013.08.016_b0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","article-title":"Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases","volume":"41","author":"Aggarwal","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"10.1016\/j.mehy.2013.08.016_b0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2006-957450","article-title":"Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers","volume":"64","author":"Shoba","year":"1998","journal-title":"Planta Med"},{"issue":"13","key":"10.1016\/j.mehy.2013.08.016_b0115","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ejca.2005.05.009","article-title":"Curcumin: the story so far","volume":"41","author":"Sharma","year":"2005","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.mehy.2013.08.016_b0120","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/1055-9965.EPI-07-2693","article-title":"Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects","volume":"17","author":"Vareed","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.mehy.2013.08.016_b0125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1165\/rcmb.2011-0175OC","article-title":"Pulmonary administration of a water-soluble curcumin complex reduces severity of acute lung injury","volume":"47","author":"Suresh","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"20","key":"10.1016\/j.mehy.2013.08.016_b0130","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clin Cancer Res"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713004052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713004052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T20:01:46Z","timestamp":1539460906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987713004052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0306987713004052"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2013.08.016","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of curcumin in idiopathic pulmonary arterial hypertension treatment: A new therapeutic possibility","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2013.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}